Alnylam Pharmaceuticals Inc

ALNY NASDAQ Santé & Biotech États-Unis US02043Q1076
281.90 $
2.05 %

Alnylam Pharmaceuticals Inc est une entreprise biopharmaceutique qui se concentre sur le développement de thérapies basées sur l'ARN interférent.

Performance & Momentum

6 Months 27.75 %
1 Year 8.16 %
3 Years 43.19 %
5 Years 59.90 %

Similar stocks to Alnylam Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Alnylam Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases